☰

Transition to New HIV Treatment Regimens – Procurement and Supply Chain Management Issues. Policy Brief

This policy brief provides advice on a phased approach to transitioning to new HIV treatment regimens, as recommended by the World Health Organization (WHO). The ultimate purpose is to ensure a continuous supply of antiretroviral (ARV) drugs, and ensure rapid and efficient implementation of the new WHO ARV guidelines, with smooth transitioning to new recommended ARV regimens, while reducing the wastage or expiry of products that are no longer recommended.

Management, Policy, Procurement

  • Sub-categories HIV/AIDS
  • Commodities Diagnostics, Medicines
  • Latest update March 2014
  • Version
  • Developed by WHO
  • When to use This policy brief provides advice on a phased approach to transitioning to new HIV treatment regimens, as recommended by the World Health Organization (WHO). The ultimate purpose is to ensure a continuous supply of antiretroviral (ARV) drugs, and ensure rapid and efficient implementation of the new WHO ARV guidelines, with smooth transitioning to new recommended ARV regimens, while reducing the wastage or expiry of products that are no longer recommended.
  • Languages English
  • Level of use Central
  • Form pdf file
  • Amount of training / TA required n/a
  • Inputs & outputs n/a
  • Cost Free
  • Advantages n/a
  • Limitations n/a
  • Availability http://apps.who.int/iris/bitstream/10665/104449/1/WHO_HIV_2014.4_eng.pdf?ua=1
  • Remarks n/a
  • Contact hiv-aids@who.int
  • Submission date 2014-03-22 23:55:38